variant,gene_symbol,summary,clinical_importance,evidence,impact,frequency,category,inheritance,zygosity,PMIDs,dbSNP_ID,penetrance_score,build_37_chromosome,build_37_position,build_37_variant_allele,getev_report_url
APOE-C130R,APOE,"This is generally known as the ApoE4 allele of ApoE and is associated with increased risk of Alzheimer's. 20-25% of individuals are heterozygous for this variant, and 1-2% are homozygous. Data from Khachaturian et al. suggests an average 7% of all individuals developed Alzheimer's by the age of 80; when this is split by ApoE4 status: 10% of ApoE4 heterozygotes (3% increased attributable risk), 40% of ApoE4 homozygotes (33% increased attributable risk), and 5% of non-carriers (2% decreased attributable risk). Notably, their model suggests 70-75% of people would eventually develop Alzheimer's by the age of 100 regardless of ApoE4 genotype (and 25-30% are resistant, regardless of genotype), but that ApoE4 variants shift the disease onset to occur significantly earlier (4 years earlier for heterozygous carriers, 13 years for homozygotes).",High,Well-established,Pathogenic,0.14,Mental and behavioral;Nervous system,Complex/Other,Heterozygous,9343467;11950276;15123497;17428983,rs429358,4,chr19,45411941,C,http://evidence.personalgenomes.org/genomes?display_genome_id=f8666a717ad559fb997b74c27d6f49cd4ff452c3&access_token=423f31d448a308421ccd6dc397eb61fb
THBD-P495S,THBD,"Reported to cause familial hemolytic-uremic syndrome in a dominant manner, a potentially lethal illness in children. If true, penetrance is not 100%, but some family history of the illness might be expected.",High,Uncertain,Pathogenic,0.0011,Blood;Genital and urinary,Dominant,Heterozygous,19625716,,4,chr20,23028659,A,http://evidence.personalgenomes.org/genomes?display_genome_id=f8666a717ad559fb997b74c27d6f49cd4ff452c3&access_token=423f31d448a308421ccd6dc397eb61fb
PEX2-W250R,PEX2,"Unreported, predicted to be damaging. Other recessive missense mutations in this gene cause severe disorders involving defects in peroxisomes.",High,Uncertain,Pathogenic,0.008,Other,Recessive,Heterozygous,10528859,,4,chr8,77895667,G,http://evidence.personalgenomes.org/genomes?display_genome_id=f8666a717ad559fb997b74c27d6f49cd4ff452c3&access_token=423f31d448a308421ccd6dc397eb61fb
PEX1-I696M,PEX1,"Reported as a mutation causing peroxisome biogenesis disorder in a single patient, presumably in a recessive manner.",High,Uncertain,Pathogenic,0.027,Metabolism,Recessive,Heterozygous,11389485,rs35996821,5,chr7,92132493,C,http://evidence.personalgenomes.org/genomes?display_genome_id=f8666a717ad559fb997b74c27d6f49cd4ff452c3&access_token=423f31d448a308421ccd6dc397eb61fb
C3-R102G,C3,"This variant (also called C3F) is common in Europeans (10.2% allele frequency), and is associated with age-related macular degeneration. In the US, 1.5% of adults over 40 have the disease, but the incidence increases strongly with age (>15% in women over 80). Assuming an average lifetime risk of ~10%, heterozygous individuals have a ~13% risk and homozygous have ~20%.",Moderate,Likely,Pathogenic,0.15,Hearing and vision,Complex/Other,Heterozygous,4427677;17634448,rs2230199,3,chr19,6718387,C,http://evidence.personalgenomes.org/genomes?display_genome_id=f8666a717ad559fb997b74c27d6f49cd4ff452c3&access_token=423f31d448a308421ccd6dc397eb61fb
UGT1A1-G71R,UGT1A1,"This variant, also known as UGT1A1*6, is associated with Gilbert syndrome (found in ~5% of the population) and transient hyperbilirubinemia in infants in east asian populations. This allele appears to have incomplete penetrance and causes reduced enzyme activity.",Moderate,Likely,Pathogenic,0.00074,"Mouth, liver, and digestive",Complex/Other,Heterozygous,9929972;18004206,rs4148323,3,chr2,234669144,A,http://evidence.personalgenomes.org/genomes?display_genome_id=f8666a717ad559fb997b74c27d6f49cd4ff452c3&access_token=423f31d448a308421ccd6dc397eb61fb
MATN3-T303M,MATN3,"An Iceland study implicated this in causing increased osteoarthritis -- in particular, hand osteoarthritis. Because the variant is rare, the statistical significance of observations is weak. The authors estimate that individuals heterozygous for this variant have a 2.1-fold risk for hand osteoarthritis.",Moderate,Uncertain,Pathogenic,0.011,"Muscular, skeletal, and connective tissue",Unknown,Heterozygous,12736871,rs77245812,3,chr2,20202930,A,http://evidence.personalgenomes.org/genomes?display_genome_id=f8666a717ad559fb997b74c27d6f49cd4ff452c3&access_token=423f31d448a308421ccd6dc397eb61fb
COL4A1-Q1334H,COL4A1,"This common variant has been associated with arterial stiffness and, in Japanese, a small increased risk of myocardial infarction (MI, a.k.a. heart attack). This last observation supported a dominant effect for this variant and, assuming a lifetime risk of 15% for MI, we estimate carriers have an additional risk of 0.5-3%.",Low,Likely,Pathogenic,0.32,Heart and circulatory,Dominant,Heterozygous,10334796;18077766;20031579,rs3742207,2,chr13,110818598,G,http://evidence.personalgenomes.org/genomes?display_genome_id=f8666a717ad559fb997b74c27d6f49cd4ff452c3&access_token=423f31d448a308421ccd6dc397eb61fb
rs5186,,"This common noncoding genetic variant has an allele frequency of ~30% and is associated with an increased risk of hypertension. If ~25% of non-carriers have hypertension, Bonnardeaux et al's data predict ~4% increased risk of hypertension per copy of this variant. This SNP is in the 3' noncoding region of the AGTR1 transcript (angiotensin II type 1 receptor), also known as AT2R1 or AT1R, which is a target of hypertension drugs.",Low,Likely,Pathogenic,0.21,Drug response;Heart and circulatory,Unknown,Homozygous,"8021009;
11250978;11593098;16046653;16675453;17668390",rs5186,2,chr3,148459988,C,http://evidence.personalgenomes.org/genomes?display_genome_id=f8666a717ad559fb997b74c27d6f49cd4ff452c3&access_token=423f31d448a308421ccd6dc397eb61fb
MTRR-I49M,MTRR,"This common variant (HapMap allele frequency of 31.3%) in a protein involved in folate (B9) and cobalamin (B12) metabolism and is often reported as ""MTRR I22M"" (an alternative transcript position). Mothers homozygous for this variant are associated with having around a increased chance of a child with Down syndrome (risk of 0.4%, average risk in population is 0.25%). Notably, age plays a far larger role in the rate of Down syndrome (risk is 4.5% for a mother 45-years-of-age), and it is unknown how this variant may combine with the effect of age. There are conflicting reports associating this variant with incidence of neural tube defects, possibly when combined with MTHFR A222V.",Low,Likely,Pathogenic,0.45,Anatomical and congenital;Metabolism;Nervous system,Recessive,Heterozygous,10444342;10930360;11807890;12375236;15060097;15979034;17024475,rs1801394,1,chr5,7870973,G,http://evidence.personalgenomes.org/genomes?display_genome_id=f8666a717ad559fb997b74c27d6f49cd4ff452c3&access_token=423f31d448a308421ccd6dc397eb61fb
ELAC2-S217L,ELAC2,"Reported to be associated with increased susceptibility to prostate cancer, but later studies weaken the hypothesis. Xu et al.'s meta-analysis concludes that there is a small but significant increased risk (OR = 1.13). Assuming a lifetime risk of 16% for prostate cancer we calculate this leads to an increased risk of ~1.5% (17.5% total).",Low,Uncertain,Pathogenic,0.27,Cancer;Genital and urinary,Complex/Other,Heterozygous,12384782;15368467;18767027;20231859,rs4792311,2,chr17,12915009,A,http://evidence.personalgenomes.org/genomes?display_genome_id=f8666a717ad559fb997b74c27d6f49cd4ff452c3&access_token=423f31d448a308421ccd6dc397eb61fb
TGIF1-P83Shift,TGIF1,"Severe variants in this gene are associated with holoprosencephaly disorders when combined with loss-of-function variants in SHH. Haploinsufficiency was identified in some families with this condition. It is unclear how likely this variant is to occur in combination with an SHH variant, or what phenotypic effect the variant would have on its own.",Low,Uncertain,Pathogenic,0.14,Nervous system,Complex/Other,Heterozygous,10556296,rs11571510,1,,,,http://evidence.personalgenomes.org/genomes?display_genome_id=f8666a717ad559fb997b74c27d6f49cd4ff452c3&access_token=423f31d448a308421ccd6dc397eb61fb
WFS1-R611H,WFS1,"This nonsynonymous SNP is associated with Wolfram Syndrome (known as DIDMOAD), which is characterized by early-onset non-autoimmune diabetes mellitus, diabetes insipidus, optic atrophy, and deafness) and to adult Type Two Diabetes Mellitus.  The WFS1 gene maps to chromosome 4p16.3.  The variant has been shown to be statistically associated with type II diabetes in six UK studies and one study of Ashkenazi Jews (Sandhu, M., et al., Minton et al.).",Low,Uncertain,Not Reviewed,0.4,Hearing and vision;Immune system;Metabolism,Recessive,Heterozygous,17603484;17719176;23257691,rs734312,1,chr4,6303354,A,http://evidence.personalgenomes.org/genomes?display_genome_id=f8666a717ad559fb997b74c27d6f49cd4ff452c3&access_token=423f31d448a308421ccd6dc397eb61fb
ERCC6-R1213G,ERCC6,"When homozygous, this variant may cause Cockayne Syndrome, which is a severe autosomal-recessive disorder characterized by abnormal early growth and development, abnormal sensitivity to sunlight, and premature aging. Cockayne Syndrome Type I and Type II lead to death in early childhood. Several other variants in the ERCC6 gene are linked to Cockayne Syndrome. This variant may also be linked to age-related macular degeneration like other ERCC6 variants, and has been linked to colorectal cancer in one study. ",Low,Uncertain,Pathogenic,0.2,Anatomical and congenital;Cancer;Hearing and vision,Recessive,Heterozygous,,rs2228527,0,chr10,50678369,C,http://evidence.personalgenomes.org/genomes?display_genome_id=f8666a717ad559fb997b74c27d6f49cd4ff452c3&access_token=423f31d448a308421ccd6dc397eb61fb
SP110-L425S,SP110,"This variant is associated with a slightly increased risk of tuberculosis. It is unclear whether it is itself causal, or in linkage disequilibrium with some other causal variant that has a stronger effect.",Low,Uncertain,Pathogenic,0.86,Immune system,Unknown,Heterozygous,16803959,rs3948464,1,chr2,231050715,G,http://evidence.personalgenomes.org/genomes?display_genome_id=f8666a717ad559fb997b74c27d6f49cd4ff452c3&access_token=423f31d448a308421ccd6dc397eb61fb
BRCA2-N372H,BRCA2,"This is a common variant of BRCA2 (HapMap allele frequency of 23%). The variant is weakly associated with an increased chance of breast cancer, and zygosity of the variant is associated with sex of children: male children are more likely to be homozygous for this variant, female children are more likely to be heterozygous.",Low,Uncertain,Pathogenic,0.24,Cancer,Recessive,Heterozygous,11062481;15235023,rs144848,2,chr13,32906729,C,http://evidence.personalgenomes.org/genomes?display_genome_id=f8666a717ad559fb997b74c27d6f49cd4ff452c3&access_token=423f31d448a308421ccd6dc397eb61fb
TP53-P72R,TP53,"This is a common variant was first reported as a polymorphism. It has since had mixed associations with cancer: Storey et al. conclude a 7x *increased* risk of HPV cancer for homozygotes vs hets, but Jones et al. find a 1.98x *decreased* risk for colorectal cancer. This variant may have significant impact on particular cancers, but it is unclear what effect it has on the overall burden of cancer.",Low,Uncertain,Pathogenic,0.63,Cancer,Unknown,Heterozygous,1975675;9607760;15355915;19837266;20615891;22184967,rs1042522,0,chr17,7579472,C,http://evidence.personalgenomes.org/genomes?display_genome_id=f8666a717ad559fb997b74c27d6f49cd4ff452c3&access_token=423f31d448a308421ccd6dc397eb61fb
DPYD-M166V,DPYD,Associated with DPYD deficiency and poor prognosis for chemotherapy w/ 5-flurorouracil. ,High,Likely,Pharmacogenetic,0.078,Other,Unknown,Heterozygous,11895907;14635116;19104657,rs2297595,5,chr1,98165091,C,http://evidence.personalgenomes.org/genomes?display_genome_id=f8666a717ad559fb997b74c27d6f49cd4ff452c3&access_token=423f31d448a308421ccd6dc397eb61fb
TPMT-Y240C,TPMT,"Alone, this variant is known as TPMT*3C -- but often, especially in Caucasians, it is found together with another nonsynonymous variant (A154T) to produce the TPMT*3A variant. Both variants are associated with loss of thiopurine methyltransferase (TPMT) activity, although *3C is milder than *3A. Inability to metabolize thiopurine drugs can lead to severe adverse reactions. Heterozygotes may be advised to take a reduced dosage due to reduced metabolism of the drug.",Low,Well-established,Pharmacogenetic,0.046,Drug response;Metabolism,Complex/Other,Heterozygous,15228163;15298741;20154640;20354201,rs1142345,2,chr6,18130918,C,http://evidence.personalgenomes.org/genomes?display_genome_id=f8666a717ad559fb997b74c27d6f49cd4ff452c3&access_token=423f31d448a308421ccd6dc397eb61fb
TPMT-A154T,TPMT,"Usually this variant is found in combination Y240C, forming the TPMT*3A variant. When alone, this variant produces the *3B variant. Both variants are associated with loss of thiopurine methyltransferase (TPMT) activity. Inability to metabolize thiopurine drugs can lead to severe adverse reactions. Heterozygotes may be advised to take a reduced dosage due to reduced metabolism of the drug.",Low,Likely,Pharmacogenetic,0.028,Drug response;Metabolism,Recessive,Heterozygous,15228163;15298741;20154640;20354201,rs1800460,2,chr6,18139228,T,http://evidence.personalgenomes.org/genomes?display_genome_id=f8666a717ad559fb997b74c27d6f49cd4ff452c3&access_token=423f31d448a308421ccd6dc397eb61fb
FUT2-W154X,FUT2,"This recessive protective variant confers resistance to norovirus (which causes stomach flu). 20% of Caucasians and Africans are homozygous for this variant and are ""non-secretors"": they do not express ABO blood type antigens in their saliva or mucosal surfaces. Most strains of norovirus bind to these antigens in the gut, and so this non-secretor status confers almost total resistantance to most types of norovirus. There are notable exceptions, some strains of norovirus bind a different target and are equally infectious for secretors and non-secretors.",Moderate,Well-established,Protective,0.49,Blood;Immune system,Recessive,Homozygous,7876235;12692541;19625485;20031047;22025362,rs601338,5,chr19,49206674,A,http://evidence.personalgenomes.org/genomes?display_genome_id=f8666a717ad559fb997b74c27d6f49cd4ff452c3&access_token=423f31d448a308421ccd6dc397eb61fb
PRNP-M129V,PRNP,"This variant is associated with some protective effects for prion disease -- individuals homozygous for this variant are less susceptible to Creutzfeldt-Jakob, and Papua New Guinea individuals heterozygotes at this site are less susceptible to kuru.

",Low,Well-established,Protective,0.34,Other,Complex/Other,Heterozygous,18236005;19081515,rs1799990,0,chr20,4680251,G,http://evidence.personalgenomes.org/genomes?display_genome_id=f8666a717ad559fb997b74c27d6f49cd4ff452c3&access_token=423f31d448a308421ccd6dc397eb61fb
CFH-V62I,CFH,"Associated with a decreased risk for age related macular degeneration (ARMD). Homozygotes for this have a 4-5% decreased attributable risk (3-4% vs. average 8% risk), heterozygotes have slightly lower than average risk (7%). Non-carriers have an increased risk (12-13%). ARMD impairs sharp vision as age progresses. While there is no cure, treatment can slow progression of the disease and environmental factors (smoking and obesity) contribute to higher risk.",Low,Likely,Protective,0.39,Hearing and vision;Metabolism,Complex/Other,Heterozygous,15870199,rs800292,2,chr1,196642233,A,http://evidence.personalgenomes.org/genomes?display_genome_id=f8666a717ad559fb997b74c27d6f49cd4ff452c3&access_token=423f31d448a308421ccd6dc397eb61fb
NPC1-H215R,NPC1,"This variant is associated with a reduced risk of obesity, with an additive effect of -0.084 BMI per allele (an average of 0.54 pounds less, per allele, in a 5'6"" individual).





",Low,Likely,Protective,0.3,Metabolism,Complex/Other,Heterozygous,19151714;19174833;19910939,rs1805081,2,chr18,21140432,C,http://evidence.personalgenomes.org/genomes?display_genome_id=f8666a717ad559fb997b74c27d6f49cd4ff452c3&access_token=423f31d448a308421ccd6dc397eb61fb
MTR-D919G,MTR,"This variant was weakly associated with a protective effect vs. colorectal cancer, but only in individuals with low alcohol consumption.


",Low,Uncertain,Protective,0.22,Cancer,Complex/Other,Heterozygous,10498402;14744749;17417062;17855192,rs1805087,1,chr1,237048500,G,http://evidence.personalgenomes.org/genomes?display_genome_id=f8666a717ad559fb997b74c27d6f49cd4ff452c3&access_token=423f31d448a308421ccd6dc397eb61fb
IRS2-G1057D,IRS2,"a.k.a Gly1057Asp, insulin receptor substrate-2 IRS2. The rs1805097(G) allele is associated with the Gly, and the (A) allele with Asp. 
A longevity study concluded that rs1805097(A;A) individuals were about twice as likely to live over 85 y/o (odds ratio 2.03, CI:1.39-2.99, p = .0003). ",Low,Uncertain,Protective,0.23,Other,Unknown,Heterozygous,19887537,rs1805097,,chr13,110435231,T,http://evidence.personalgenomes.org/genomes?display_genome_id=f8666a717ad559fb997b74c27d6f49cd4ff452c3&access_token=423f31d448a308421ccd6dc397eb61fb
LPL-S474X,LPL,"This variant actually increases LPL enzyme activity despite creating a termination codon (see Rip J et al). It appears to be a protective variant, associated with lower triglyceride levels--although the effect is quite weak and explains only 0.5-1% of triglyceride variation.",Low,Uncertain,Protective,0.084,Metabolism,Unknown,Heterozygous,16574898;17463246;18193044;19802338;20429872;22042884,rs328,,chr8,19819724,G,http://evidence.personalgenomes.org/genomes?display_genome_id=f8666a717ad559fb997b74c27d6f49cd4ff452c3&access_token=423f31d448a308421ccd6dc397eb61fb
DTNBP1-P272S,DTNBP1,Possibly a slight protective effect against colorectal cancer if homozygous.,Low,Uncertain,Protective,0.035,Cancer,Recessive,Heterozygous,17000706,rs17470454,2,chr6,15523448,A,http://evidence.personalgenomes.org/genomes?display_genome_id=f8666a717ad559fb997b74c27d6f49cd4ff452c3&access_token=423f31d448a308421ccd6dc397eb61fb
TYR-R402Q,TYR,"This is a frequent pigmentation polymorphism in Europeans that affects function of the Tyrosinase gene. It is associated with blue instead of green eyes and sun sensitivity. For the most part this variant is benign, but many individuals with ocular albinism (which affects only the eyes) carry this variant along with another more severe variant in the same gene.",Low,Well-established,Benign,0.2,Hearing and vision,Complex/Other,Heterozygous,1820207;7704033;11284711;18326704;18488027;18488028;19533789,rs1126809,0,chr11,89017961,A,http://evidence.personalgenomes.org/genomes?display_genome_id=f8666a717ad559fb997b74c27d6f49cd4ff452c3&access_token=423f31d448a308421ccd6dc397eb61fb
ARSA-N350S,ARSA,This common variant (HapMap 24.1% allele frequency) causes a loss of a glycosylation site (affecting the size of the protein when studied with gel electrophoresis) but does not affect enzyme activity or stability.,Low,Well-established,Benign,0.18,Other,Unknown,Homozygous,2574462,rs2071421,,chr22,51064416,C,http://evidence.personalgenomes.org/genomes?display_genome_id=f8666a717ad559fb997b74c27d6f49cd4ff452c3&access_token=423f31d448a308421ccd6dc397eb61fb
PMS2-P470S,PMS2,"Benign, common variant.",Low,Likely,Benign,0.37,Other,Unknown,Heterozygous,15256438,rs1805321,,chr7,6026988,A,http://evidence.personalgenomes.org/genomes?display_genome_id=f8666a717ad559fb997b74c27d6f49cd4ff452c3&access_token=423f31d448a308421ccd6dc397eb61fb
CACNA1S-L458H,CACNA1S,Common polymorphism,Low,Likely,Benign,0.27,Other,Unknown,Heterozygous,,rs12742169,,chr1,201052310,T,http://evidence.personalgenomes.org/genomes?display_genome_id=f8666a717ad559fb997b74c27d6f49cd4ff452c3&access_token=423f31d448a308421ccd6dc397eb61fb
GUCY2D-A52S,GUCY2D,"One publication suggested that this variant possibly causes Leber's congenital amaurosis in a recessive manner, but the frequency data (36% in 1000 genomes) contradicts any significant pathogenic effect.",Low,Uncertain,Benign,0.21,Hearing and vision,Recessive,Homozygous,8944027,rs61749665,,chr17,7906519,T,http://evidence.personalgenomes.org/genomes?display_genome_id=f8666a717ad559fb997b74c27d6f49cd4ff452c3&access_token=423f31d448a308421ccd6dc397eb61fb
RPGRIP1-A547S,RPGRIP1,"Probably benign. Implicated in causing autosomal recessive cone-rod dystrophy, but a later report found the same incidence in controls and concludes it is not causal.",Low,Uncertain,Benign,0.23,Hearing and vision,Complex/Other,Heterozygous,12920076;16272259,rs10151259,,chr14,21790040,T,http://evidence.personalgenomes.org/genomes?display_genome_id=f8666a717ad559fb997b74c27d6f49cd4ff452c3&access_token=423f31d448a308421ccd6dc397eb61fb
LOXL1-R141L,LOXL1,"Associated with exfoliative glaucoma & syndrome (XFG & XFS) in various populations, but with contradicting results (protective in Caucasians, pathogenic in Japanese). Based on this it seems the variation itself -- although it affects protein structure -- is not itself causing disease. Instead it is likely associated with other nearby causal variants. As such, it is evaluated as benign by GET-Evidence (which focuses on reporting causal variants). See detailed variant report for disease risk associations.",Low,Uncertain,Benign,0.26,Hearing and vision,Complex/Other,Heterozygous,17690259;18450598;20142848,rs1048661,,chr15,74219546,T,http://evidence.personalgenomes.org/genomes?display_genome_id=f8666a717ad559fb997b74c27d6f49cd4ff452c3&access_token=423f31d448a308421ccd6dc397eb61fb
COL7A1-P1277L,COL7A1,"Polymorphism, presumed benign.",Low,Uncertain,Benign,0.041,Other,Unknown,Heterozygous,,rs35761247,,chr3,48623124,A,http://evidence.personalgenomes.org/genomes?display_genome_id=f8666a717ad559fb997b74c27d6f49cd4ff452c3&access_token=423f31d448a308421ccd6dc397eb61fb
APOB-Y1422C,APOB,This position is almost certainly an error in the HG18 reference sequence. ,Low,Uncertain,Benign,1.0,Other,Unknown,Homozygous,,rs568413,,chr2,21235475,C,http://evidence.personalgenomes.org/genomes?display_genome_id=f8666a717ad559fb997b74c27d6f49cd4ff452c3&access_token=423f31d448a308421ccd6dc397eb61fb
VWF-G2705R,VWF,"Probably benign, seems to be considered an uncommon polymorphism.",Low,Uncertain,Benign,0.046,Other,Unknown,Heterozygous,11439975,rs7962217,,chr12,6061559,T,http://evidence.personalgenomes.org/genomes?display_genome_id=f8666a717ad559fb997b74c27d6f49cd4ff452c3&access_token=423f31d448a308421ccd6dc397eb61fb
PHYH-P29S,PHYH,"Probably benign. This variant was implicated as causing Refsum Disease in a recessive manner, but a subsequent publication noted that all instances were linked with other explanatory mutations. The high allele frequency of this variant in the population (7-13%) contradicts a pathogenic hypothesis.",Low,Uncertain,Benign,0.16,Nervous system,Unknown,Heterozygous,10767344;14974078,rs28938169,0,chr10,13340236,A,http://evidence.personalgenomes.org/genomes?display_genome_id=f8666a717ad559fb997b74c27d6f49cd4ff452c3&access_token=423f31d448a308421ccd6dc397eb61fb
SLC45A2-L374F,SLC45A2,"Pigmentation allele for non-black hair, and consequently, possible increased susceptibility to malignant melanoma.",Low,Uncertain,Benign,0.69,Cancer,Unknown,Homozygous,15714523;17044855;18563784;18806926,rs16891982,,chr5,33951693,G,http://evidence.personalgenomes.org/genomes?display_genome_id=f8666a717ad559fb997b74c27d6f49cd4ff452c3&access_token=423f31d448a308421ccd6dc397eb61fb
CYP27A1-P384L,CYP27A1,"Probably not pathogenic. Although predicted to be disruptive and treated by some as pathogenic, reports of this variant in cases were all linked with an upstream frameshift variant -- this supports the variant as a nonpathogenic ancestral polymorphism.",Low,Uncertain,Benign,0.018,Other,Unknown,Heterozygous,"
7860076;10775536;16500955",rs41272687,,chr2,219678877,T,http://evidence.personalgenomes.org/genomes?display_genome_id=f8666a717ad559fb997b74c27d6f49cd4ff452c3&access_token=423f31d448a308421ccd6dc397eb61fb
TAS2R38-I296V,TAS2R38,"This variant is associated with ""taster"" status of PTC, along with 49P and 262A. Due to linkage disequilibrium, the independent effects of positions 296 and 262 is unclear. The presence of 49P confers taster status in a dominant fashion, but in the absence of 49P, the presence of 262A/296V is still positively associated with tasting PTC.",Low,Uncertain,Benign,0.46,Other,Unknown,Heterozygous,12595690;20675712,rs10246939,,chr7,141672604,C,http://evidence.personalgenomes.org/genomes?display_genome_id=f8666a717ad559fb997b74c27d6f49cd4ff452c3&access_token=423f31d448a308421ccd6dc397eb61fb
SDHB-S163P,SDHB,"We evaluate as uncertain but presumed benign. One report linked this variant to Cowden-like syndromes, but the significance of their findings is unclear and other reports treat this as a non-pathological variation.",Low,Uncertain,Benign,0.01,Cancer,Unknown,Heterozygous,17102082;18678321,rs33927012,,chr1,17354297,G,http://evidence.personalgenomes.org/genomes?display_genome_id=f8666a717ad559fb997b74c27d6f49cd4ff452c3&access_token=423f31d448a308421ccd6dc397eb61fb
TYR-S192Y,TYR,This variant is reported to affect skin pigmentation. It is associated with lighter skin in South Asians (OR 4-5) and with a lack of freckles in Europeans (OR 1.3).,Low,Uncertain,Benign,0.27,Skin,Unknown,Homozygous,17952075;17999355,rs1042602,,chr11,88911696,A,http://evidence.personalgenomes.org/genomes?display_genome_id=f8666a717ad559fb997b74c27d6f49cd4ff452c3&access_token=423f31d448a308421ccd6dc397eb61fb
PCSK9-G670E,PCSK9,This variant is likely benign. ,Low,Uncertain,Benign,0.89,Other,Unknown,Homozygous,19351729,rs505151,,chr1,55529187,A,http://evidence.personalgenomes.org/genomes?display_genome_id=f8666a717ad559fb997b74c27d6f49cd4ff452c3&access_token=423f31d448a308421ccd6dc397eb61fb
TAS2R38-A49P,TAS2R38,"This variant is strongly associated with causing the ""taster"" phenotype of phenylthiocarbamine (PTC) in a dominant manner.",Low,Uncertain,Benign,0.43,Other,Unknown,Heterozygous,12595690;15883422;20675712,rs713598,,chr7,141673345,G,http://evidence.personalgenomes.org/genomes?display_genome_id=f8666a717ad559fb997b74c27d6f49cd4ff452c3&access_token=423f31d448a308421ccd6dc397eb61fb
RP1-N985Y,RP1,"Probably benign. One report linked this variant to high triglycerides, but a later paper found a nearby SNP with similar association and suggests that both findings are caused by linkage to an undiscovered causal variant.",Low,Uncertain,Benign,0.35,Metabolism,Unknown,Heterozygous,12764676;19364639,rs2293869,,chr8,55539395,T,http://evidence.personalgenomes.org/genomes?display_genome_id=f8666a717ad559fb997b74c27d6f49cd4ff452c3&access_token=423f31d448a308421ccd6dc397eb61fb
